Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
Current Treatment Options in Gastroenterology
|
February 12, 2016
Treat to Target in Inflammatory Bowel Disease
Peter Bossuyt, Séverine Vermeire
BMC Medicine
|
May 9, 2019
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
Lieven Pouillon, Séverine Vermeire, Peter Bossuyt
Journal of Crohn'S & Colitis
|
October 26, 2020
Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath
Bram Verstockt, Lieven Pouillon, Peter Bossuyt
Gastroenterology
|
August 18, 2020
Assessing Disease Activity in Ulcerative Colitis Using Artificial Intelligence: Can "Equally Good" Be Seen as "Better"?
Peter Bossuyt, Séverine Vermeire, Raf Bisschops
Journal of Crohn'S & Colitis
|
August 31, 2021
Is Also the Patient Ready for Switching from Intravenous to Subcutaneous Biologics?
Katrien Asnong, Lieven Pouillon, Peter Bossuyt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 23, 2018
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases
Peter Bossuyt, Eveline Hoefkens, Lieven Pouillon
Gut
|
April 8, 2019
Scoring endoscopic disease activity in IBD: artificial intelligence sees more and better than we do
Peter Bossuyt, Séverine Vermeire, Raf Bisschops
Gastroenterology
|
August 1, 2017
Tofacitinib Is the Right OCTAVE for Ulcerative Colitis
Lieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
Gastroenterology
|
March 5, 2022
Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader
Anne-Marie Delsupehe, Claire Bourgain, Peter Bossuyt
United European Gastroenterology Journal
|
August 5, 2020
Endoscopic treatment of large symptomatic colon lipomas: A systematic review of efficacy and safety
Michiel Bronswijk, Anne-Marie Vandenbroucke, Peter Bossuyt
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
Current Treatment Options in Gastroenterology
|
February 12, 2016
Treat to Target in Inflammatory Bowel Disease
Peter Bossuyt, Séverine Vermeire
BMC Medicine
|
May 9, 2019
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
Lieven Pouillon, Séverine Vermeire, Peter Bossuyt
Journal of Crohn'S & Colitis
|
October 26, 2020
Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath
Bram Verstockt, Lieven Pouillon, Peter Bossuyt
Gastroenterology
|
August 18, 2020
Assessing Disease Activity in Ulcerative Colitis Using Artificial Intelligence: Can "Equally Good" Be Seen as "Better"?
Peter Bossuyt, Séverine Vermeire, Raf Bisschops
Journal of Crohn'S & Colitis
|
August 31, 2021
Is Also the Patient Ready for Switching from Intravenous to Subcutaneous Biologics?
Katrien Asnong, Lieven Pouillon, Peter Bossuyt
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 23, 2018
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases
Peter Bossuyt, Eveline Hoefkens, Lieven Pouillon
Gut
|
April 8, 2019
Scoring endoscopic disease activity in IBD: artificial intelligence sees more and better than we do
Peter Bossuyt, Séverine Vermeire, Raf Bisschops
Gastroenterology
|
August 1, 2017
Tofacitinib Is the Right OCTAVE for Ulcerative Colitis
Lieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
Gastroenterology
|
March 5, 2022
Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader
Anne-Marie Delsupehe, Claire Bourgain, Peter Bossuyt
United European Gastroenterology Journal
|
August 5, 2020
Endoscopic treatment of large symptomatic colon lipomas: A systematic review of efficacy and safety
Michiel Bronswijk, Anne-Marie Vandenbroucke, Peter Bossuyt
Page
of 14